Home / People / Marion Wyler
Portrait of Marion Wyler

Marion Wyler


CMS von Erlach Partners Ltd
Dreikönigstrasse 7
P.O. Box
8022 Zurich
Languages German, English, French

Marion Wyler focuses her practice on Life Sciences & Healthcare as well as Competition Law.

In the field of Life Sciences & Healthcare, Marion Wyler supports primarily clients active in pharma, medtech, biotech and healthcare. Her practice includes advising on all regulatory issues, M&A transactions and sector-typical contracts.

Marion Wyler also has vast experience across all areas of Competition Law, both contentious and non-contentious, with particular focus on cartel investigations and litigation, (cross-border) mergers and competition issues in distribution.

In 2014 Marion Wyler has been admitted to the bar and has since been working with CMS. She lectures at the Zurich University of Applied Sciences ZHAW and Careum School for Healthcare Professions, and regularly publishes in her area of expertise.

more less

'Competent and quick' associate Marion Wyler is also recommended.

The Legal 500, Healthcare and life sciences, Switzerland, 2019

Relevant experience

  • Advising and representing Bank Julius Baer in proceedings of the Swiss Competition Commission regarding currency trading and precious metals trading
  • Advising and representing an international bank in proceedings of the Swiss Competition Commission regarding reference interest rates (“Libor”)
  • Advising and representing Bayer Schweiz AG in proceedings before the Swiss Federal Supreme Court regarding alleged vertical price-fixing of drugs not covered by health insurance (“Hors-Liste”)
  • Longstanding counselling of various entities of the synlab-group in their daily business in all regulatory aspects (e.g., advertising of IVD products, development and implementation of collaboration agreements, setting up of compliance guidelines and providing of related staff training)
  • Advising Kieser Training AG on drawing up and implementing its worldwide franchise concept
  • Advised Rieter on the acquisition of the SSM division from Schweiter (coordination of multi-jurisdictional merger control)
  • Advised Nextclinics on the acquisition of IVF-Zentren Prof. Zech (a group of clinics active in reproductive medicine)
  • Advising various leading international companies in relation to distribution arrangements as well as complex cooperations with customers, suppliers and competitors
  • Developing and implementing antitrust compliance frameworks and codes of conduct in relation to dawn raids by competition authorities
  • Advising various pharmaceutical companies and healthcare providers on product distribution, particularly in the area of advertising and financial benefits (i.e., discounts, kickbacks, sponsoring, etc.)
  • Advised a major dental chain in all areas of healthcare law, particularly in relation to authorisations and protection of patient personal data (stored in overseas cloud)
  • Advised a world-leading online retailer on importing infant formula from the EU into Switzerland
  • Advised a world-leading pharmaceutical company in the field of reproductive medicine (in particular with regard to preimplantation diagnosis)
  • Advised foreign companies on trading cord blood (and tissue) and on importing blood plasma into Switzerland
more less

Memberships & Roles

  • Zurich Bar Association (ZAV)
  • Swiss Bar Association (SBA)
  • Studienvereinigung Kartellrecht
  • Berkeley Global Society
more less

Lectures list

  • Ecosystems – presentation on digital ecosystems from an antitrust perspective, Business Engineering Institute St. Gallen, 12 February 2020
  • CMS Breakfast regarding Competition and Procurement law – presentation on Antitrust, Procurement and Civil Law consequences of prohibited behaviour, 31 October 2018
  • Caregiving for mentally ill patients – lecture on legal framework related to the protection of adults, such as deputyship and care-related hospitalisation at Zurich University of Applied Sciences ZHAW (since January 2016)
  • Introduction to Healthcare Law – lecture on patient’s rights, data privacy, medical secrecy and medical malpractice liability at Zurich University of Applied Sciences ZHAW (since September 2015)
  • Introduction to Employment Law – lecture given at Careum School for Healthcare Professions (since August 2015)
  • Compliance training – provided to synlab staff regarding new cooperation agreements and internal compliance guidelines, 5 July and 11 October 2017
  • Law at the doctor’s office – elementary rules of handling patients; caregiving of mentally ill patients; cooperations and financial benefits among healthcare professionals, seminar provided at “Wissen.Praxis”, 8 June 2017
  • Presentations in Healthcare and Contract Law for various clients’ staff
more less


  • 2019 – LL.M. candidate at UC Berkeley
  • 2014 – Bar admission, Switzerland
  • 2011 – Master of Law, University of Fribourg (Switzerland) and University of Durham (UK)
  • 2009 – Additional Diploma “bilingue plus” (German and French), issued by the Faculty of Arts of the University of Fribourg
  • 2009 – Bachelor of Law, with the additions “bilingual” (German/French) and “European Law”, University of Fribourg
more less
CMS Com­mer­cial Guide: Dis­tri­bu­tion and Agency Agree­ments
Agency Agree­ments & Dis­tri­bu­tion Agree­ments While many as­pects of the dis­tri­bu­tion re­la­tion­ship will be sim­il­ar when dis­trib­ut­ing with­in the EU, there are im­port­ant and po­ten­tially costly dif­fer­ences...


Vac­cine com­pens­a­tion re­gimes in Switzer­land
1. Are COV­ID-19 vac­cin­a­tions ob­lig­at­ory in your jur­is­dic­tion? Are you ex­pect­ing any le­gis­lat­ive changes to en­able man­dat­ory vac­cines for all or cer­tain people (e.g. health­care pro­fes­sion­als, pub­lic ser­vants...
Can­nabis law and le­gis­la­tion in Switzer­land
Med­ic­al use Grow­ing, selling and im­port­ing can­nabis for med­ic­al use is al­lowed.However, there is a dis­tinc­tion between can­nabis con­tain­ing at least 1% THC and oth­er can­nabis. Fur­ther­more, un­like THC...
The Fed­er­al Su­preme Court's judg­ment in the mat­ter "Hors-Liste Medika­mente...
On 21 April 2021, the Fed­er­al Su­preme Court pub­lished a judg­ment against Pf­izer re­gard­ing the sanc­tion or­der of the Com­pet­i­tion Com­mis­sion (COMCO) in the mat­ter Hors-Liste Medika­mente (Pre­isem­p­fehlun­gen)...
CMS Switzer­land ranked by The Leg­al 500
Rank­ings of CMS Switzer­land in The Leg­al 500 EMEA 2021 edi­tion CMS Switzer­land is re­com­men­ded in 18 cat­egor­ies in this year's Europe, Middle East and Africa edi­tion of The Leg­al 500, pub­lished in April...
Phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising in...
1. Which laws are ap­plic­able re­gard­ing ad­vert­ising of medi­cines and med­ic­al devices? 1.1 Medi­cines The key stat­utes reg­u­lat­ing ad­vert­ising and pro­mo­tion of medi­cin­al products are:The Fed­er­al Act on...
CMS ad­vised the own­er of Ak­tiengesell­schaft Ernst Hablützel + Co. on the...
After many years of op­er­at­ing the fam­ily busi­ness in the fourth gen­er­a­tion, the own­er of Ak­tiengesell­schaft Ernst Hablützel + Co., has de­cided to ar­range his suc­ces­sion in time and thus se­cure the long-term...
Life Sci­ences & Health­care Prac­tice Group Switzer­land
Your spe­cial­ists in the field of Life Sci­ences & Health­care Our Life Sci­ences & Health­care team con­sists of spe­cial­ised at­tor­neys who will ad­vise and rep­res­ent you in all leg­al mat­ters com­pet­ently and...
New rank­ings from "The Leg­al 500" for CMS Switzer­land
New rank­ings from "The Leg­al 500" for CMS Switzer­land CMS Switzer­land is be­ing re­com­men­ded in 16 cat­egor­ies in this year's edi­tion of The Leg­al 500, pub­lished in April 2020. We are par­tic­u­larly pleased...
CMS ad­vised Conzz­eta on the sale of Schmid Rhyner Group
CMS ad­vised Conzz­eta on the sale of Schmid Rhyner Group Swiss lis­ted Conzz­eta AG and the Ger­man spe­cialty chem­ic­als group ALTANA have agreed that ALTANA ac­quires the Schmid Rhyner Group from Conzz­eta.With­in...
CMS Switzer­land fur­ther im­proves its rank­ing with The Leg­al 500
CMS Switzer­land fur­ther im­proves its rank­ing with The Leg­al 500 We are de­lighted to an­nounce that CMS Switzer­land is be­ing re­com­men­ded in 12 cat­egor­ies in this year's edi­tion of The Leg­al 500, pub­lished...
CMS ad­vises share­hold­ers on the sale of Or­bi­um to Ac­cen­ture
CMS ad­vises share­hold­ers on the sale of Or­bi­um to Ac­cen­tur­eAc­cen­ture, a lead­ing glob­al pro­fes­sion­al ser­vices com­pany, provid­ing a broad range of ser­vices and solu­tions in strategy, con­sult­ing, di­git­al...
CMS ad­vises Fon­cia Group on the ac­quis­i­tion of GRIBI Group
CMS ad­vises Fon­cia Group on the ac­quis­i­tion of GRIBI Group DBS Im­mob­ilier SA, the Swiss sub­si­di­ary of the French real es­tate group Fon­cia, which is European's mar­ket lead­er in the man­age­ment of res­id­en­tial...